Search Results - "Karyakin, O"

Refine Results
  1. 1

    Phase II trial of second-line everolimus in patients with metastatic renal cell carcinoma (RECORD-4) by Motzer, R.J., Alyasova, A., Ye, D., Karpenko, A., Li, H., Alekseev, B., Xie, L., Kurteva, G., Kowalyszyn, R., Karyakin, O., Neron, Y., Cosgriff, T., Collins, L., Brechenmacher, T., Lin, C., Morgan, L., Yang, L.

    Published in Annals of oncology (01-03-2016)
    “…RECORD-1 demonstrated clinical benefit of everolimus in patients with metastatic renal cell carcinoma (mRCC) previously treated with sunitinib, sorafenib, or…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4

    A Programmable System for Assessing the State of Health and Efficacy of Treatment of the Prostate Gland by Korenevskiy, N. A., Seregin, S. P., Karyakin, O. B., Biryukov, V. A., Dolzhenkov, S. D., Dmitrieva, V. V.

    Published in Biomedical engineering (01-05-2019)
    “…The challenge of constructing a programmable system for assessing the state of health of the prostate gland is considered. The mathematical apparatus for…”
    Get full text
    Journal Article
  5. 5

    Trimodal organ‑preserving treatment of muscle‑invasive bladder cancer by A. V. Troianov, I. O. Dementev, I. N. Zaborsky, V. S. Chaykov, O. B. Karyakin, Yu. V. Gumenetskaya

    Published in Issledovaniâ i praktika v medicine (26-03-2023)
    “…Purpose of the study. Generalization of the world experience of organ‑preserving treatment in muscle‑invasive bladder cancerMaterials and methods. The…”
    Get full text
    Journal Article
  6. 6

    Combined treatment of high and very high risk prostate cancer: results of neoadjuvant treatment by A. V. Troyanov, V. A. Biryukov, I. V. Zaborsky, V. S. Chaykov, I. O. Dementev, E. O. Shchukina, O. B. Karyakin

    Published in Issledovaniâ i praktika v medicine (01-06-2023)
    “…Purpose of the study. Assessment of safety and short‑term effectiveness of high and very high‑risk prostate cancer neoadjuvant chemo‑ hormonal treatment…”
    Get full text
    Journal Article
  7. 7

    The role of biomarkers of acute kidney injury in predicting functional outcomes of surgical treatment of patients with localized kidney cancer by I. O. Dementev, K. M. Nyushko, O. B. Karyakin, V. S. Chaikov, A. V. Troyanov, I. N. Zaborskii, E. O. Shchukina

    Published in Issledovaniâ i praktika v medicine (26-09-2021)
    “…Currently, due to the dynamic development of surgical technologies, indications for organ-sparing treatment of kidney cancer are expanding. Acute kidney injury…”
    Get full text
    Journal Article
  8. 8
  9. 9

    The Changes of Properties of Blood Peripheral Lymphocytes of Donors and Patients with Prostate Gland Cancer: Reaction of Lymphocytes on Irradiation in vitro by Pelevina, I I, Aleshchenko, A V, Antoshchina, M M, Biryukov, V A, Karyakin, O B, Reva, E V, Serebryanyi, A M

    “…The oxidative status (ROS), markers activation expression (CD69), proliferation activity (Ki67), proapoptotic antigen (CD95) have been investigated on healthy…”
    Get more information
    Journal Article
  10. 10

    Current capabilities of endoscopic diagnosis of non-muscle invasive bladder cancer by I. N. Zaborskii, K. N. Safiullin, O. B. Karyakin, S. A. Ivanov, V. S. Chaikov, I. O. Dementev, A. V. Sidorin, G. N. Grishin, A. N. Yurchenko

    Published in Issledovaniâ i praktika v medicine (25-06-2020)
    “…Abstract In recent years, there has been a steady increase in the incidence of bladder cancer (RMP) in our country. So, over the past ten years there has been…”
    Get full text
    Journal Article
  11. 11

    Combined modality radiotherapy for high-risk prostate cancer. Analysis of treatment-Related complications by Makarova, K. S., Gumenetskaya, Yu. V., Biryukov, V. A., Obukhov, A. A., Strikanova, I. A., Dzhabrailova, S. O., Lepilina, O. G., Borysheva, N. B., Karyakin, O. B., Ivanov, S. A., Kaprin, A. D.

    Published in Sibirskiĭ onkologicheskiĭ zhurnal (26-04-2019)
    “…Purpose : to analyze toxicity of combined modality radiotherapy in high-risk prostate cancer patients. Material and methods. Short-term outcomes after combined…”
    Get full text
    Journal Article
  12. 12

    Some molecular-genetic markers defining the pathogenesis of superficial and invasive bladder cancer by Babayan, A. Yu, Karyakin, O. B., Teplov, A. A., Zaletaev, D. V., Nemtsova, M. V.

    Published in Molecular biology (New York) (01-12-2011)
    “…We investigated deletions of 3p14, 9p21, 9q34, 17p13 (TP53) loci, activating FGFR3 mutations in exon 9, and aberrant methylation of RASSF1, RAR β, P16, P14,…”
    Get full text
    Journal Article
  13. 13

    RESULTS OF CLINICAL TRIALS OF MEDICAL TREA TMENT OF RENAL CELL CARCINOMA IN 2014–2015 by A. M. Popov, O. B. Karyakin, A. D. Kaprin

    Published in Issledovaniâ i praktika v medicine (13-01-2016)
    “…Over the last decade there have been significant changes in the approaches to the drug treatment of renal cell carcinoma. In clinical practice, there was a…”
    Get full text
    Journal Article
  14. 14
  15. 15

    CLINICAL CASE OF TREATMENT OF INVASIVE UROTHELIAL CANCER OF THE UPPER URINARY TRACT. PROBLEMS OF COMBINED TREATMENT by A. A. Klimenko, I. P. Kostyuk, O. B. Karyakin, S. A. Moserov, Z. N. Shavladze, I. N. Zaborsky, V. S. Chaykov, M. E. Tarasova

    Published in Issledovaniâ i praktika v medicine (27-03-2018)
    “…This article presents a clinical observation of the treatment of recurrent invasive urothelial cancer of the upper urinary tract using surgical and…”
    Get full text
    Journal Article
  16. 16

    DOSE-ESCALATED EXTERNAL BEAM RADIOTHERAPY DURING HORMONO-RADIOTHERAPY FOR PROSTATE CANCER by Gumenetskaya, Yu. V., Mardynskiy, Yu. S., Gulidov, I. A., Karyakin, O. B., Chaykov, V. S.

    Published in Sibirskiĭ onkologicheskiĭ zhurnal (01-07-2016)
    “…Introduction. The introduction of modern technologies of conformal external beam radiotherapy (EBRT) into clinical practice for the treatment of prostate…”
    Get full text
    Journal Article
  17. 17

    LOW POWER BRACHYTHERAPY IN COMBINED TREATMENT IN PATIENTS WITH INTERMEDIATE RISK OF LOCALIZED PROST ATE CANCER by V. A. Biryukov, O. B. Karyakin, O. V. Morov, O. G. Lepilina, D. V. Neledov, D. B. Sanin, G. N. Grishin, M. S. Kalinina

    Published in Issledovaniâ i praktika v medicine (16-01-2015)
    “…Objective. Estimation of the effectiveness of low power brachytherapy sources I-125 in the combined treatment in group of patients of intermediate risk…”
    Get full text
    Journal Article
  18. 18

    VHL inactivation in sporadic clear cell renal carcinoma by Mikhaylenko, D S, Kurynin, R V, Popov, A M, Karyakin, O B, Enikeev, M E, Alyaev, Yu G, Nemtsova, M V, Zaletayev, D V

    Published in Molecular biology (New York) (01-02-2008)
    “…Clear cell renal carcinoma (CCRC) accounts for 75% of all renal cancer cases. The majority of CCRCs displays inactivation of the VHL suppressor gene as a…”
    Get full text
    Journal Article
  19. 19
  20. 20

    An experience with dose-escalated conformal radiation therapy in hormone-radiotherapy for prostate cancer by Gumenetskaya, Yu V, Mardynsky, Yu S, Karyakin, O B, Gulidov, I A, Biryukov, V A

    Published in Voprosy onkologij (2015)
    “…This study presents the short-term outcomes of conformal external beam radiation therapy given in conjunction with hormone therapy to 110 patients with…”
    Get more information
    Journal Article